Fernando Gonzalez, MD

Title(s)Professor, Pediatrics
SchoolSchool of Medicine
Address1550 Fourth St, #548C
San Francisco CA 94158
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Brown University, Providence, RISc.B.1997Neuroscience
    Brown University, Providence, RIM.D.2001School of Medicine
    Harbor-UCLA Medical Center, Torrance, CA2004Pediatrics
    UCSF, San Francisco, CA2007Neonatal-Perinatal Medicine
    University of California, San Francisco, CA2019Diversity, Equity, and Inclusion Champion Training

    Collapse Overview 
    Collapse Overview
    My research is focused on determining how the full-term brain responds to acute injury during the neonatal period, and strategies to enhance neuroplasticity and long-term functional outcomes. My specific research goals are to: (1) clearly define the neuronal subpopulations that are vulnerable to ischemia and critical for neurodevelopment, (2) determine the mechanisms of injury and endogenous repair in the immature brain, and (3) define therapeutic strategies to enhance long-term function. Specifically, I am interested in how the immature brain differs from the adult brain in its response to stroke, and how reparative mechanisms can be enhanced with delayed therapy. Throughout my training, I have had broad exposure to various aspects of central nervous system (CNS) development and repair, including: evaluation and inhibition of pain through direct CNS treatment; the effects of local injury on wound healing and phagocytosis; direct evaluation of behavioral, cognitive, and nociceptive function after injury; pathophysiologic mechanisms of early brain injury; and the effects of exogenous therapy on early brain injury. Of these experiences, the ones I found most compelling were those that linked rigorous basic science at the bench to investigation of human disease. For example, my research on the short-term effects of exogenous erythropoietin treatment on neurogenesis after early rodent stroke prompted a study to determine beneficial treatment strategies that improve long-term functional outcomes. This project showed that prolonged erythropoietin treatment is most effective for long-term behavioral improvement, a finding that informed clinical studies in humans to treat neonatal brain injury. My current research is focused on cell type-specific changes in the peri-infarct cortex, including alterations in cell fate, function, and circuit formation. This will have a significant impact in improving knowledge and identifying novel therapies to treat early injury. It is my clear desire to apply this type of translational approach to the field of neonatal brain injury, thereby unifying my interest in neuroscience and brain development with a goal of improving the care of the newborn.
    Collapse Mentoring

    Collapse Research 
    Collapse Research Activities and Funding
    COOL Prime: Comparative Effectiveness for Cooling mild HIE
    PCORI PCORI PIR-1552Nov 1, 2022 - Oct 31, 2027
    Role: Site-PI
    Description: This is a comparative effectiveness evaluation of cooling for mild HIE (Hypoxic-ischemic encephalopathy) within a prospective cohort of infants at 14 academic centers whose practices are mixed for either therapeutic hypothermia or supportive care. The central aim is to determine if there are differences in the primary outcome of Bayley 4 exams at 2 years, Child Behavior Checklist and Hammersmith Neonatal and Infant Neurological Exams, in infants meeting predefined criteria for mild HIE based on the use of cooling or supportive care. Furthermore, this study aims to determine and infant safety composite outcome to determine the risk of therapeutic hypothermia versus normothermia in this population and the effect on mother-infant measures or stress, bonding and breastfeeding at 3-4 months of age.
    Endothelial tip cell-mediated angiogenesis and repair after neonatal stroke
    NIH/NINDS 2R01NS107039Sep 22, 2022 - Aug 31, 2027
    Role: PI
    Description: To determine role of EPO in modulating angiogenesis and fibrosis as a delayed treatment strategy for neonatal stroke.
    The Child Health Research Career Development Program at UCSF
    NIH/NICHD K12HD105250Apr 1, 2021 - Mar 31, 2026
    Role: Co-I, Recruitment Director
    Description: This program is an investment in the future of children’s health, as the diverse group of researchers we will train will harness advanced research strategies to address urgent problems (e.g., asthma, cancer, infectious diseases, host defense defects, diabetes, obesity and developmental malformations of the heart, brain and other organs), resulting in new treatments to improve child health outcomes.
    Quantifying Metabolic Changes in the Newborn Brain Following Stroke
    NIH/NCATS RAS A127522Jun 1, 2018 - May 31, 2019
    Role: PI
    Enhanced cellular therapy for neonatal stroke
    NIH R01NS107039Dec 15, 2017 - Nov 30, 2021
    Role: Principal Investigator
    Description: The goal of this project is to determine the mechanisms of regeneration and repair with delayed cellular therapy for neonatal stroke by focusing on the vascular response to brain injury. This will study the effects of mesenchymal stem cells pre-treated with erythropoietin on long-term outcomes.
    Cerebral focal ischemia-reperfusion injury
    Anida Pharma, Inc. AnidaMar 1, 2017 - Feb 28, 2018
    Role: Co-investigator
    Precision Therapy for Neonatal Brain Injury
    NIH R35NS097299Dec 1, 2016 - Nov 30, 2024
    Role: Co-Investigator
    High-dose Erythropoietin for Asphyxia and Encephalopathy (HEAL) CCC
    NIH U01NS092764Sep 30, 2016 - Jun 30, 2021
    Role: Site-PI, Executive Committee Member
    The Role of Erythropoietin in Enhancing Synaptic Plasticity and Neural Circuit Formation after Neonatal Stroke
    UCSF REACJan 1, 2015 - Jun 30, 2016
    Role: PI
    Repair after Neonatal Brain Injury
    NIH P01NS082330Jan 1, 2014 - Dec 31, 2020
    Role: Co-Investigator
    Harrington DiscoveryJan 1, 2014 - Dec 31, 2015
    Role: Co-Investigator
    Effects of neonatal stroke and erythropoietin on cell fate and neurogenesis
    UCSF RAPJan 1, 2012 - Dec 31, 2014
    Role: PI
    Erythropoietin and Neurogenesis after Neonatal Stroke
    NIH K08NS064094Mar 1, 2011 - Feb 29, 2016
    Role: Principal Investigator
    Mechanisms of Ischemic Neonatal Brain Injury
    NIH P50NS035902Apr 1, 1997 - Jan 31, 2015
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Publications
    Collapse Collaboration Interests

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Genetic and Congenital Anomalies in Infants With Hypoxic-Ischemic Encephalopathy. Pediatr Neurol. 2024 May; 154:44-50. Morell AS, Monsell SE, Cornet MC, Wisnowski JL, McKinstry RC, Mathur AM, Li Y, Glass HC, Gonzalez FF, Mayock DE, Benninger KL, Van Meurs KP, Lampland AL, Wu TW, Riley D, Mietzsch U, Chalak L, Flibotte J, Weitkamp JH, Ahmad KA, Yanowitz TD, Baserga M, Merhar S, Rao R, Sokol GM, Comstock BA, Heagerty PJ, Juul SE, Wu YW. PMID: 38518503.
      View in: PubMed   Mentions:    Fields:    
    2. Evolution of the Sarnat exam and association with 2-year outcomes in infants with moderate or severe hypoxic-ischaemic encephalopathy: a secondary analysis of the HEAL Trial. Arch Dis Child Fetal Neonatal Ed. 2023 Nov 27. Mietzsch U, Kolnik SE, Wood TR, Natarajan N, Gonzalez FF, Glass H, Mayock DE, Bonifacio SL, Van Meurs K, Comstock BA, Heagerty PJ, Wu TW, Wu YW, Juul SE, HEAL Trial Study Group. PMID: 38071538.
      View in: PubMed   Mentions:    Fields:    
    3. Association of EEG Background and Neurodevelopmental Outcome in Neonates With Hypoxic-Ischemic Encephalopathy Receiving Hypothermia. Neurology. 2023 Nov 27; 101(22):e2223-e2233. Glass HC, Numis AL, Comstock BA, Gonzalez FF, Mietzsch U, Bonifacio SL, Massey S, Thomas C, Natarajan N, Mayock DE, Sokol GM, Van Meurs KP, Ahmad KA, Maitre N, Heagerty PJ, Juul SE, Wu YW, Wusthoff CJ. PMID: 37816642; PMCID: PMC10727206.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Time to Reaching Target Cooling Temperature and 2-year Outcomes in Infants with Hypoxic-Ischemic Encephalopathy. J Pediatr. 2024 Mar; 266:113853. Rao R, Comstock BA, Wu TW, Mietzsch U, Mayock DE, Gonzalez FF, Wood TR, Heagerty PJ, Juul SE, Wu YW. PMID: 38006967.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    5. Early Glycemic State and Outcomes of Neonates With Hypoxic-Ischemic Encephalopathy. Pediatrics. 2023 10 01; 152(4). Mietzsch U, Wood TR, Wu TW, Natarajan N, Glass HC, Gonzalez FF, Mayock DE, Comstock BA, Heagerty PJ, Juul SE, Wu YW, HEAL Study Group. PMID: 37655394; PMCID: PMC10522925.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Placental Histologic Abnormalities and 2-Year Outcomes in Neonatal Hypoxic-Ischemic Encephalopathy. Neonatology. 2023; 120(6):760-767. Gonzalez FF, Voldal E, Comstock BA, Mayock DE, Goodman AM, Cornet MC, Wu TW, Redline RW, Heagerty P, Juul SE, Wu YW. PMID: 37742617; PMCID: PMC10711751.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Safety of High Dose Erythropoietin Used with Therapeutic Hypothermia as Treatment for Newborn Hypoxic-Ischemic Encephalopathy: Secondary Analysis of the HEAL Randomized Controlled Trial. J Pediatr. 2023 07; 258:113400. Juul SE, Comstock BA, Cornet MC, Gonzalez FF, Mayock DE, Glass HC, Schreiber MD, Heagerty PJ, Wu YW. PMID: 37019334; PMCID: PMC10760810.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    8. How well does neonatal neuroimaging correlate with neurodevelopmental outcomes in infants with hypoxic-ischemic encephalopathy? Pediatr Res. 2023 09; 94(3):1018-1025. Wu YW, Monsell SE, Glass HC, Wisnowski JL, Mathur AM, McKinstry RC, Bluml S, Gonzalez FF, Comstock BA, Heagerty PJ, Juul SE. PMID: 36859442; PMCID: PMC10444609.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    9. Risk of seizures in neonates with hypoxic-ischemic encephalopathy receiving hypothermia plus erythropoietin or placebo. Pediatr Res. 2023 07; 94(1):252-259. Glass HC, Wusthoff CJ, Comstock BA, Numis AL, Gonzalez FF, Maitre N, Massey SL, Mayock DE, Mietzsch U, Natarajan N, Sokol GM, Bonifacio SL, Van Meurs KP, Thomas C, Ahmad KA, Heagerty PJ, Juul SE, Wu YW. PMID: 36470964; PMCID: PMC10239788.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    10. Trial of Erythropoietin for Hypoxic-Ischemic Encephalopathy in Newborns. N Engl J Med. 2022 07 14; 387(2):148-159. Wu YW, Comstock BA, Gonzalez FF, Mayock DE, Goodman AM, Maitre NL, Chang T, Van Meurs KP, Lampland AL, Bendel-Stenzel E, Mathur AM, Wu TW, Riley D, Mietzsch U, Chalak L, Flibotte J, Weitkamp JH, Ahmad KA, Yanowitz TD, Baserga M, Poindexter BB, Rogers EE, Lowe JR, Kuban KCK, O'Shea TM, Wisnowski JL, McKinstry RC, Bluml S, Bonifacio S, Benninger KL, Rao R, Smyser CD, Sokol GM, Merhar S, Schreiber MD, Glass HC, Heagerty PJ, Juul SE, HEAL Consortium. PMID: 35830641; PMCID: PMC10542745.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    11. Interleukin-15 modulates the response of cortical neurons to ischemia. Mol Cell Neurosci. 2021 09; 115:103658. Nguyen V, Ameri K, Huynh K, Fredkin M, Grona R, Larpthaveesarp A, Gonzalez F, Yeghiazarians Y. PMID: 34343628.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    12. Physician-Scientist Training and Programming in Pediatric Residency Programs: A National Survey. J Pediatr. 2022 02; 241:5-9.e3. Burns AM, Moore DJ, Forster CS, Powell W, Thammasitboon S, Hostetter MK, Weiss P, Boyer D, Ward MA, Blankenburg R, Heyman MB, Rassbach CE, McPhillips H, French A, Nguyen S, Byrne BJ, Parsons DW, Gonzalez F, Nowalk AJ, Ho J, Kumar S, Orange JS, Ackerman KG. PMID: 34280401.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    13. Update on mechanisms of the pathophysiology of neonatal encephalopathy. Semin Fetal Neonatal Med. 2021 10; 26(5):101267. Davidson JO, Gonzalez F, Gressens P, Gunn AJ, Newborn Brain Society Guidelines and Publications Committee. PMID: 34274259.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    14. Acute and Chronic Placental Abnormalities in a Multicenter Cohort of Newborn Infants with Hypoxic-Ischemic Encephalopathy. J Pediatr. 2021 Oct; 237:190-196. Chalak L, Redline RW, Goodman AM, Juul SE, Chang T, Yanowitz TD, Maitre N, Mayock DE, Lampland AL, Bendel-Stenzel E, Riley D, Mathur AM, Rao R, Van Meurs KP, Wu TW, Gonzalez FF, Flibotte J, Mietzsch U, Sokol GM, Ahmad KA, Baserga M, Weitkamp JH, Poindexter BB, Comstock BA, Wu YW. PMID: 34144032.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    15. Neuroprotective effects of Sonic hedgehog agonist SAG in a rat model of neonatal stroke. Pediatr Res. 2021 12; 90(6):1161-1170. Nguyen V, Chavali M, Larpthaveesarp A, Kodali S, Gonzalez G, Franklin RJM, Rowitch DH, Gonzalez F. PMID: 33654279; PMCID: PMC8410885.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    16. Perspectives from the Society for Pediatric Research: advice on sustaining science and mentoring during COVID-19. Pediatr Res. 2021 10; 90(4):738-743. Forster CS, Nguyen ST, Powell WT, Moore DJ, Ho J, Heyman MB, Wenger TL, Gonzalez F, Hostetter M, Nowalk A, Rassbach CE, Boyer D, Weiss P, Blankenburg RL, Orange JS, Ackerman KG, Burns AM, National Pediatric Physician-Scientist Collaborative Workgroup. PMID: 33469179; PMCID: PMC7814517.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    17. Enhanced Mesenchymal Stromal Cells or Erythropoietin Provide Long-Term Functional Benefit After Neonatal Stroke. Stroke. 2021 01; 52(1):284-293. Larpthaveesarp A, Pathipati P, Ostrin S, Rajah A, Ferriero D, Gonzalez FF. PMID: 33349013; PMCID: PMC7770074.
      View in: PubMed   Mentions: 14     Fields:    Translation:Animals
    18. Caffeine Restores Background EEG Activity Independent of Infarct Reduction after Neonatal Hypoxic Ischemic Brain Injury. Dev Neurosci. 2020; 42(1):72-82. Sun H, Gonzalez F, McQuillen PS. PMID: 32810862; PMCID: PMC7486269.
      View in: PubMed   Mentions: 7     Fields:    Translation:Animals
    19. A new genetic strategy for targeting microglia in development and disease. Elife. 2020 06 23; 9. McKinsey GL, Lizama CO, Keown-Lang AE, Niu A, Santander N, Larpthaveesarp A, Chee E, Gonzalez FF, Arnold TD. PMID: 32573436; PMCID: PMC7375817.
      View in: PubMed   Mentions: 63     Fields:    Translation:AnimalsCells
    20. Whither pediatric physician-scientist training in the COVID-19 era. Pediatr Res. 2021 04; 89(5):1041-1042. Gonzalez FF, Heyman MB. PMID: 32575111.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    21. Neuroprotection Strategies for Term Encephalopathy. Semin Pediatr Neurol. 2019 12; 32:100773. Gonzalez FF. PMID: 31813519; PMCID: PMC6934049.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    22. Placental pathology and neonatal brain MRI in a randomized trial of erythropoietin for hypoxic-ischemic encephalopathy. Pediatr Res. 2020 04; 87(5):879-884. Wu YW, Goodman AM, Chang T, Mulkey SB, Gonzalez FF, Mayock DE, Juul SE, Mathur AM, Van Meurs K, McKinstry RC, Redline RW. PMID: 31261373.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    23. Recommendations for the design of therapeutic trials for neonatal seizures. Pediatr Res. 2019 06; 85(7):943-954. Soul JS, Pressler R, Allen M, Boylan G, Rabe H, Portman R, Hardy P, Zohar S, Romero K, Tseng B, Bhatt-Mehta V, Hahn C, Denne S, Auvin S, Vinks A, Lantos J, Marlow N, Davis JM, International Neonatal Consortium. PMID: 30584262; PMCID: PMC6760680.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    24. Predictive value of early EEG for seizures in neonates with hypoxic-ischemic encephalopathy undergoing therapeutic hypothermia. Pediatr Res. 2018 09; 84(3):399-402. Cornet MC, Pasupuleti A, Fang A, Gonzalez F, Shimotake T, Ferriero DM, Glass HC, Cilio MR. PMID: 29895836.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    25. High-Dose Erythropoietin for Asphyxia and Encephalopathy (HEAL): A Randomized Controlled Trial - Background, Aims, and Study Protocol. Neonatology. 2018; 113(4):331-338. Juul SE, Comstock BA, Heagerty PJ, Mayock DE, Goodman AM, Hauge S, Gonzalez F, Wu YW. PMID: 29514165; PMCID: PMC5980685.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCTClinical Trials
    26. Transient Middle Cerebral Artery Occlusion Model of Neonatal Stroke in P10 Rats. J Vis Exp. 2017 04 21; (122). Larpthaveesarp A, Gonzalez FF. PMID: 28518065; PMCID: PMC5565067.
      View in: PubMed   Mentions: 5     Fields:    Translation:Animals
    27. High-Dose Erythropoietin and Hypothermia for Hypoxic-Ischemic Encephalopathy: A Phase II Trial. Pediatrics. 2016 06; 137(6). Wu YW, Mathur AM, Chang T, McKinstry RC, Mulkey SB, Mayock DE, Van Meurs KP, Rogers EE, Gonzalez FF, Comstock BA, Juul SE, Msall ME, Bonifacio SL, Glass HC, Massaro AN, Dong L, Tan KW, Heagerty PJ, Ballard RA. PMID: 27244862.
      View in: PubMed   Mentions: 81     Fields:    Translation:HumansCTClinical Trials
    28. Delayed erythropoietin therapy improves histological and behavioral outcomes after transient neonatal stroke. Neurobiol Dis. 2016 09; 93:57-63. Larpthaveesarp A, Georgevits M, Ferriero DM, Gonzalez FF. PMID: 27142685; PMCID: PMC4930700.
      View in: PubMed   Mentions: 33     Fields:    Translation:AnimalsCells
    29. Growth factors for the treatment of ischemic brain injury (growth factor treatment). Brain Sci. 2015 Apr 30; 5(2):165-77. Larpthaveesarp A, Ferriero DM, Gonzalez FF. PMID: 25942688; PMCID: PMC4493462.
      View in: PubMed   Mentions: 29  
    30. Erythropoietin: a novel therapy for hypoxic-ischaemic encephalopathy? Dev Med Child Neurol. 2015 Apr; 57 Suppl 3:34-9. Wu YW, Gonzalez FF. PMID: 25800490.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimals
    31. Stem cells for neonatal stroke- the future is here. Front Cell Neurosci. 2014; 8:207. van Velthoven CT, Gonzalez F, Vexler ZS, Ferriero DM. PMID: 25120432; PMCID: PMC4110439.
      View in: PubMed   Mentions: 12  
    32. Erythropoietin increases neurogenesis and oligodendrogliosis of subventricular zone precursor cells after neonatal stroke. Stroke. 2013 Mar; 44(3):753-8. Gonzalez FF, Larpthaveesarp A, McQuillen P, Derugin N, Wendland M, Spadafora R, Ferriero DM. PMID: 23391775; PMCID: PMC3689426.
      View in: PubMed   Mentions: 67     Fields:    Translation:AnimalsCells
    33. An overview of risk factors for poor neurodevelopmental outcome associated with prematurity. World J Pediatr. 2012 Nov; 8(4):293-300. Xiong T, Gonzalez F, Mu DZ. PMID: 23151855.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    34. Effects of combination therapy using hypothermia and erythropoietin in a rat model of neonatal hypoxia-ischemia. Pediatr Res. 2013 Jan; 73(1):12-7. Fang AY, Gonzalez FF, Sheldon RA, Ferriero DM. PMID: 23085817; PMCID: PMC3540182.
      View in: PubMed   Mentions: 48     Fields:    Translation:Animals
    35. Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics. Pediatrics. 2012 Oct; 130(4):683-91. Wu YW, Bauer LA, Ballard RA, Ferriero DM, Glidden DV, Mayock DE, Chang T, Durand DJ, Song D, Bonifacio SL, Gonzalez FF, Glass HC, Juul SE. PMID: 23008465; PMCID: PMC3457622.
      View in: PubMed   Mentions: 81     Fields:    Translation:HumansCTClinical Trials
    36. Is erythropoietin the answer? Pediatr Res. 2011 Jan; 69(1):2-3. Gonzalez FF, Fang A, Ferriero DM. PMID: 21150548.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    37. Neonatal community-acquired pneumonia: pathogens and treatment. J Paediatr Child Health. 2010 Nov; 46(11):668-72. Wang H, Tang J, Xiong Y, Li X, Gonzalez F, Mu D. PMID: 20796185.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    38. Altered fate of subventricular zone progenitor cells and reduced neurogenesis following neonatal stroke. Dev Neurosci. 2010 Jul; 32(2):101-13. Spadafora R, Gonzalez FF, Derugin N, Wendland M, Ferriero D, McQuillen P. PMID: 20453463; PMCID: PMC7077090.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    39. Neuroprotection in the newborn infant. Clin Perinatol. 2009 Dec; 36(4):859-80, vii. Gonzalez FF, Ferriero DM. PMID: 19944839; PMCID: PMC2786822.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    40. Erythropoietin sustains cognitive function and brain volume after neonatal stroke. Dev Neurosci. 2009; 31(5):403-11. Gonzalez FF, Abel R, Almli CR, Mu D, Wendland M, Ferriero DM. PMID: 19672069; PMCID: PMC2820334.
      View in: PubMed   Mentions: 61     Fields:    Translation:AnimalsCells
    41. Therapeutics for neonatal brain injury. Pharmacol Ther. 2008 Oct; 120(1):43-53. Gonzalez FF, Ferriero DM. PMID: 18718848.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    42. Erythropoietin enhances long-term neuroprotection and neurogenesis in neonatal stroke. Dev Neurosci. 2007; 29(4-5):321-30. Gonzalez FF, McQuillen P, Mu D, Chang Y, Wendland M, Vexler Z, Ferriero DM. PMID: 17762200.
      View in: PubMed   Mentions: 89     Fields:    Translation:AnimalsCells
    43. Does perinatal asphyxia impair cognitive function without cerebral palsy? Arch Dis Child Fetal Neonatal Ed. 2006 Nov; 91(6):F454-9. Gonzalez FF, Miller SP. PMID: 17056843; PMCID: PMC2672766.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansAnimals
    44. Chronic desipramine treatment desensitizes the rat to anesthetic and antinociceptive effects of the alpha2-adrenergic agonist dexmedetomidine. Anesthesiology. 1998 Jun; 88(6):1634-42. Guo TZ, Reid K, Davies MF, Nacif-Coelho C, Rabin BC, Gonzalez F, Maze M. PMID: 9637658.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    Fernando's Networks
    Concepts (195)
    Derived automatically from this person's publications.
    Co-Authors (24)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department